Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kidney transplant
Biotech
Ipsen pens €700M deal to buy Swiss biotech for rare disease drug
Ipsen is on a roll this week, scooping up its second biotech in three days to firm up its pipeline with promising clinical-stage candidates.
James Waldron
Jul 1, 2026 8:05am
Memo pushes kidney drug to phase 3 despite primary endpoint miss
Jul 25, 2025 5:30am
Paragonix's donor organ perfusion system flies kidney commercial
Mar 3, 2025 12:06pm
eGenesis announces 2nd pig kidney transplant success
Feb 7, 2025 2:10pm
Northwestern surgeons transplant kidney into fully awake patient
Jun 25, 2024 2:23pm
Cell therapy allows kidney recipients to cut immunosuppressants
Nov 2, 2023 10:00am
